A primary-in-human section 1 trial (NCT03873805) investigated the security and bioactivity of prostate stem cell antigen-directed CAR T cells for sufferers with metastatic...
Orelabrutinib Plus FCG Generates Speedy Molecule Remissions in CLLOrelabrutinib together with fludarabine, cyclophosphamide, and obinutuzumab (Gazyva; FCG) produced speedy molecular remissions that deepened...